Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase
- PMID: 32455879
- PMCID: PMC7277649
- DOI: 10.3390/biom10050800
Amaryllidaceae Alkaloids of Belladine-Type from Narcissus pseudonarcissus cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase
Abstract
Thirteen known (1-12 and 16) and three previously undescribed Amaryllidaceae alkaloids of belladine structural type, named carltonine A-C (13-15), were isolated from bulbs of Narcissus pseudonarcissus cv. Carlton (Amaryllidaceae) by standard chromatographic methods. Compounds isolated in sufficient amounts, and not tested previously, were evaluated for their in vitro acetylcholinesterase (AChE; E.C. 3.1.1.7), butyrylcholinesterase (BuChE; E.C. 3.1.1.8) and prolyl oligopeptidase (POP; E.C. 3.4.21.26) inhibition activities. Significant human BuChE (hBUChE) inhibitory activity was demonstrated by newly described alkaloids carltonine A (13) and carltonine B (14) with IC50 values of 913 ± 20 nM and 31 ± 1 nM, respectively. Both compounds displayed a selective inhibition pattern for hBuChE with an outstanding selectivity profile over AChE inhibition, higher than 100. The in vitro data were further supported by in silico studies of the active alkaloids 13 and 14 in the active site of hBuChE.
Keywords: Alzheimer’s disease; Amaryllidaceae; Narcissus pseudonarcissus cv. Carlton; alkaloids; butyrylcholinesterase; carltonine A–C; docking studies.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Nichols E., Szoeke C.E.I., Vollset S.E., Abbasi N., Abd-Allah F., Abdela J., Aichour M.T.E., Akinyemi R.O., Alahdab F., Asgedom S.W., et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88–106. doi: 10.1016/S1474-4422(18)30403-4. - DOI - PMC - PubMed
-
- Hampel H., Mesulam M.-M., Cuello A.C., Farlow M.R., Giacobini E., Grossberg G.T., Khachaturian A.S., Vergallo A., Cavedo E., Snyder P.J., et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain J. Neurol. 2018;141:1917–1933. doi: 10.1093/brain/awy132. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- GA UK Nr. 178518, SVV UK 260 412, 260 401; Progres/UK Q40 and Q42/Univerzita Karlova v Praze/International
- Nr. 00179906/University Hospital Hradec Kralove/International
- Czech Science Foundation (project Nr. 20-29633J/Czech Science Foundation/International
- Long-term development plan/Faculty of Military Health Sciences/International
- Nr. CZ.02.1.01/0.0/0.0/16_019/0000841/European Union (EFSA-CDN)/International
LinkOut - more resources
Full Text Sources
